Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Menaquinone-7 (MK-7), commonly known as Vitamin K2-7, is a fat-soluble vitamin and a member of the menaquinone family, characterized by a 2-methyl-1,4-naphthoquinone ring and a side chain of seven isoprene units [1, 7, 11]. It is primarily produced by bacterial fermentation and is found in fermented foods like natto, offering superior bioavailability and a significantly longer circulatory half-life compared to Vitamin K1 [1, 12, 14]. MK-7 functions as a critical cofactor for the enzyme gamma-glutamyl carboxylase (GGCX), which facilitates the carboxylation of vitamin K-dependent proteins (VKDPs) such as osteocalcin for bone mineralization and matrix Gla protein (MGP) to prevent vascular calcification [1, 4, 14]. Beyond its role in calcium metabolism, MK-7 exhibits anti-inflammatory and anti-cancer properties by modulating signaling pathways like NF-kappaB and acting as a ligand for the pregnane X receptor (PXR) [1, 3, 7]. Clinically, it is utilized to support bone and cardiovascular health, though it poses a significant safety concern due to its ability to directly antagonize the effects of vitamin K antagonists like warfarin [16, 17].
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Menaquinone-7 (MK-7).